Department of Radiology, Medical Research Institute, Pusan National University Hospital, Pusan National University School of Medicine, 1-10, Ami-Dong, Seo-gu, Busan, 602-739, Republic of Korea.
Eur Radiol. 2021 Jul;31(7):4860-4871. doi: 10.1007/s00330-020-07644-5. Epub 2021 Jan 14.
We sought factors associated with false-negative results in the diagnosis of invasive breast cancer via non-contrast breast magnetic resonance imaging (MRI) using fused high b-value diffusion-weighted imaging (DWI) and unenhanced T1-weighted images (T1WI).
Between 2018 and 2019, 316 consecutive women (mean age, 54.6 years) with invasive breast cancer who underwent preoperative breast MRI, including fused high b-value DWI and unenhanced T1WI, were retrospectively evaluated. Malignancy confidence ratings of the most suspicious breast lesions evident on fused DWI were derived by two radiologists using a 6-point Likert-type scale. Both clinicopathological and imaging features were analyzed. Multivariate regression analysis was performed to identify factors associated with false-negative DWI results in the diagnosis of invasive breast cancer.
Of the 316 breast cancers, fused DWI yielded 289 (91.5%) true-positive and 27 (8.5%) false-negative results. Multivariate analysis showed that small tumor size (≤ 1 cm) (odds ratio [OR], 5.95; 95% confidence interval [CI], 2.11, 16.81; p = 0.001), presence of calcifications in the tumor (OR, 3.41; 95% CI, 1.27, 9.15; p = 0.015), and a moderate/marked background diffusion signal (ORs, 4.23 and 19.18; 95% CI, 1.31, 13.67 and 6.51, 56.46; p = 0.016 and p < 0.001, respectively) were significantly associated with false-negative results. In subgroup analysis of 141 screening-detected cancers, a marked background diffusion signal (OR, 7.94; 95% CI, 2.30, 27.35; p = 0.001) remained significantly associated with false-negative results in the multivariate analysis.
In addition to histopathological features, a higher background diffusion signal was associated with false-negative results in the diagnosis of invasive breast cancer via non-contrast MRI using fused high b-value DWI and unenhanced T1WI.
• Subcentimeter tumors and presence of calcifications in the tumor are associated with false-negative diffusion-weighted imaging results in the diagnosis of invasive breast cancer. • A higher degree of background diffusion signal may lead to false-negative interpretation of diffusion-weighted imaging in patients with invasive breast cancer.
我们旨在探讨使用高 b 值弥散加权成像(DWI)融合和未增强 T1 加权成像(T1WI)的非对比性乳腺磁共振成像(MRI)诊断浸润性乳腺癌时假阴性结果的相关因素。
回顾性分析了 2018 年至 2019 年间 316 例经术前乳腺 MRI(包括高 b 值 DWI 融合和未增强 T1WI)检查、诊断为浸润性乳腺癌的连续女性患者(平均年龄 54.6 岁)的资料。两位放射科医生使用 6 分 Likert 量表对最可疑的弥散加权成像上显示的乳腺病变的恶性置信度评分进行评估。分析了临床病理和影像学特征。采用多变量回归分析来确定与浸润性乳腺癌 DWI 假阴性结果相关的因素。
在 316 例乳腺癌中,融合 DWI 得出 289 例(91.5%)真阳性和 27 例(8.5%)假阴性结果。多变量分析显示,肿瘤小(≤1cm)(比值比[OR],5.95;95%置信区间[CI],2.1116.81;p=0.001)、肿瘤内存在钙化(OR,3.41;95%CI,1.279.15;p=0.015)和背景弥散信号中度/显著增高(ORs,4.23 和 19.18;95%CI,1.3113.67 和 6.5156.46;p=0.016 和 p<0.001)与假阴性结果显著相关。在 141 例筛查检出乳腺癌的亚组分析中,背景弥散信号显著增高(OR,7.94;95%CI,2.30~27.35;p=0.001)在多变量分析中仍与假阴性结果显著相关。
除了组织病理学特征外,非对比性 MRI 中使用高 b 值 DWI 融合和未增强 T1WI 诊断浸润性乳腺癌时,较高的背景弥散信号与假阴性结果相关。
亚厘米肿瘤和肿瘤内钙化与浸润性乳腺癌弥散加权成像假阴性结果相关。
背景弥散信号程度较高可能导致浸润性乳腺癌弥散加权成像的假阴性解读。